Sigut

Schwartz’s reagent – Reagent of the month August

author foto
Krystof Sigut
August 14, 2023

Schwartz's reagent - Reagent of the month August

Zirconocene chloride hydride (Schwartz's reagent, Figure 1) is an organozirconium compound used in a wide range of organic reactions.

Structure of Schwartz’s reagent
Figure 1: Structure of Schwartz’s reagent.

Preparation of Schwartz's reagent

Schwartz's reagent was first prepared by Wailes and Weigold (https://doi.org/10.1016/S0022-328X(00)80281-8) and can be prepared from zirconocene dichloride and lithium aluminium hydride. This reaction can produce dihydridozirconocene as a side product, which is readily converted to Schwartz's reagent by washing with dichloromethane (Figure 2). It commercially available, and relatively shelf stable when stored under an inert atmosphere.

Preparation of Schwartz's reagent
Figure 2: Preparation of Schwartz's reagent.

Reactivity

While Schwartz's reagent is often drawn in its monomeric form, X-ray crystallography of the crystalline reagent shows that it exists in its dimeric form (Figure 3) which has to dissociate first before the reactions can take place. Coordinating solvents such as THF help with this dissociation and thus improve reaction rates of the hydrozirconation reactions.

Dimeric form of Schwartz's reagent
Figure 3: Dimeric form of Schwartz's reagent.

It can be used for various hydrozirconation reactions on carbon-carbon double or triple bonds resulting in the corresponding alkyl or vinyl organozirconium species (Figure 4), as well as C=X hydrozirconations.

Hydrozirconation of CC double and triple bonds
Figure 4: Hydrozirconation of CC double and triple bonds.

One noteworthy example of C=X hydrozirconation is a reduction of amides to amines and aldehydes (Figure 5, https://doi.org/10.1021/ja066362). This reaction proceeds faster than other hydrozirconation reactions and can be used for selective amide cleavage even in the presence of other reducible groups such as nitriles, esters, or C=C double bonds.

Chemoselective reduction of an amide in the presence of nitrile
Figure 5: Chemoselective reduction of an amide in the presence of nitrile.

Application in synthesis

The organozirconium species obtained by hydrozirconation of CC double or triple bonds can be used as nucleophiles for a wide range of electrophilic substrates. The addition of acids such as HCl produces an alkane or alkene by neutralization of the organozirconium species and DCl can be used for isotopic labelling. Halogens such as Br2 and I2 can be used to introduce the halogen atom to the zirconium position and treating the organozirconium species with acyl chlorides results in ketone formation (Figure 6, doi:10.1021/ja00833a048).

Applications of organozirconium species obtained by hydrozirconation of alkenes
Figure 6: Applications of organozirconium species obtained by hydrozirconation of alkenes. 

This halogenation strategy was utilized in the total synthesis of a macrolide antibiotic (–)-virginiamycin M2 (Figure 7, https://doi.org/10.1021/jo202119p).

Application of Schwartz's reagent in the synthesis of (–)-Virginiamycin M2
Figure 7: Application of Schwartz's reagent in the synthesis of (–)-Virginiamycin M2.

Organozirconium compounds also undergo carbonylation under carbon monoxide atmosphere forming acylzirconium species which can be used in Pd catalysed crosscoupling reactions ( Figure 8, doi: 10.1039/b110983a).

Carbonylation of organozirconium compounds and crosscoupling reaction of the resulting acylzirconium species with diphenyliodonium tetrafluoroborate
Figure 8: Carbonylation of organozirconium compounds and crosscoupling reaction of the resulting acylzirconium species with diphenyliodonium tetrafluoroborate.

If you are interested in organic reagents, you can find more articles here.

Santiago Lab is offering custom synthesis and contract research services in the fields of organic, bioorganic and medicinal chemistry.

OUR CASE STUDY

Scale-up to accelerate drug discovery

Our experience helped overcome development hurdles for potential cancer & mental health drugs.

Read more

Empowering neuro research with pro-N6pA

Sigut Labs scaled up pro-N6pA production, simplifying AMPylation research & boosting accessibility.

Read more

ADC development leaps with new linkers

Novel linker design expedited ADC advancement, leading to promising lead compounds faster.

Read more

Lincomycin derivative scale-up

Over 30 g of the desired product with exceptional purity was obtained through our optimized procedure.

Read more

Purifying 350 kg of vitamin K2 oil

Our innovative scale-up technology helped to reduce the client’s purification process from days to hours.

Read more

Our services

What we excel in so you don’t have to

View more
Thumbnail image Custom synthesis

Custom synthesis

Providing for a custom synthesis of previously reported molecules using described synthetic procedures.

Thumbnail image Contract research

Contract research

Developing novel synthetic routes to provide undescribed compounds in organic, bioorganic, and medicinal chemistry.

Thumbnail image Scale-Up

Scale-Up

Helping you go from lab scales to an industrial scale by applying our cutting-edge instrumentation.

Contact
Kryštof

Get in touch

Krystof Sigut, CEO and Founder
arrow

Our Experts

Profile image Krystof Sigut
Krystof Sigut
- CEO and Founder -
International chemical practitioner eager to restore Czech chemistry's global prestige. Contact Krystof for inquiries, NDA signing, or business matters.
Profile image Petr Slavik
Petr Slavik
- Head of Chemistry -
Synthetic chemistry pro with a decade's diverse lab expertise. For offers, research discussions, or detailed insights, reach out to Petr directly.

Partners & distributors

logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner